Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHKA | P35790 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | ESR1 | P03372 | 1/20 | 0.39 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | UTS2R | Q9UKP6 | 1/20 | 0.36 |
| ▸ | DHFR | P00374 | 2/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL83762 | 0.91 | CHKA (0.46) | CHKACYP1A2ESR1S1PR1TSHR | |
| SCHEMBL11032897 | 0.91 | CHKA (0.46) | CHKACYP1A2ESR1S1PR1TSHR | |
| Hydrochloric Acid SCHEMBL4050783 | 0.89 | CHKA (0.44) | CHKACYP1A2ESR1S1PR1TSHR | |
| Ammonia Solution, Strong SCHEMBL7942696 | 0.89 | CHKA (0.44) | CHKACYP1A2ESR1S1PR1TSHR | |
| SCHEMBL39946 | 0.89 | ESR1 (0.44) | CYP1A2ESR1S1PR1TSHRKDM4E | |
| Benzene SCHEMBL27985319 | 0.89 | ESR1 (0.44) | CYP1A2ESR1S1PR1TSHRKDM4E | |
| SCHEMBL9818045 | 0.89 | ESR1 (0.44) | CYP1A2ESR1S1PR1TSHRKDM4E | |
| Nitrogen SCHEMBL11130833 | 0.87 | CHKA (0.43) | CHKACYP1A2ESR1S1PR1TSHR | |
| Water SCHEMBL10786878 | 0.87 | ESR1 (0.43) | CYP1A2ESR1S1PR1TSHRKDM4E | |
| Ammonia Solution, Strong SCHEMBL28398668 | 0.87 | ESR1 (0.43) | CYP1A2ESR1S1PR1TSHRKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5213699-A | For lubricants, heat and oxidation resistance | CIBA-GEIGY CORPORATION (US) | 1993-05-25 | — | — | US | claimed |
| EP-0538195-A2 | N-Allyl/benzyl substituted phenylenediamine stabilizers | CIBA-GEIGY AG (CH) | 1993-04-21 | — | — | EP | claimed |
| JP-5279304-A | — | — | None | — | — | JP | disclosed |
| EP-2245123-B1 | METHODS FOR PRODUCING ALKYLATED 1,3 BENZENEDIAMINE COMPOUNDS | CHEMTURA CORP (US) | 2017-07-19 | — | — | EP | disclosed |
| US-8563489-B2 | Alkylated 1,3-benzenediamine compounds and methods for producing same | CHEMTURA CORPORATION (US) | 2013-10-22 | — | — | US | disclosed |
| EP-2245123-A2 | ALKYLATED 1,3 BENZENEDIAMINE COMPOUNDS AND METHODS FOR PRODUCING SAME | Chemtura Corporation (US) | 2010-11-03 | — | — | EP | disclosed |
| WO-2009076091-A2 | ALKYLATED 1,3 BENZENEDIAMINE COMPOUNDS AND METHODS FOR PRODUCING SAME | CHEMTURA CORPORATION (US) | 2009-06-18 | — | — | WO | disclosed |
| US-20090156441-A1 | Cycloalkyl phenylenediamines as deposit control agents for lubricants | GREAT LAKES CHEMICAL GLOBAL, INC. | 2009-06-18 | — | — | US | disclosed |
| US-20090156449-A1 | ALKYLATED 1,3-BENZENEDIAMINE COMPOUNDS AND METHODS FOR PRODUCING SAME | LANXESS SOLUTIONS US INC. | 2009-06-18 | — | — | US | disclosed |
| JP-H05279304-A | N-ALLYL/BENZYL SUBSTITUTED PHENYLENEDIAMINE STABILIZER | CIBA GEIGY AG | 1993-10-26 | — | — | JP | disclosed |
| US-5213699-A | For lubricants, heat and oxidation resistance | CIBA-GEIGY CORPORATION (US) | 1993-05-25 | — | — | US | disclosed |
| EP-0538195-A2 | N-Allyl/benzyl substituted phenylenediamine stabilizers | CIBA-GEIGY AG (CH) | 1993-04-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090156449-A1 | ALKYLATED 1,3-BENZENEDIAMINE COMPOUNDS AND METHODS FOR PRODUCING SAME | BBOX1, ABHD5, BRD1 | CHKA 2214/4885CYP1A2 87/4885ESR1 951/4885 |
| US-20090156441-A1 | Cycloalkyl phenylenediamines as deposit control agents for lubricants | C5, C9, C1S | CHKA 980/4885CYP1A2 690/4885ESR1 2285/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.